ISRG
Intuitive Surgical Inc
399.50$
+0.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +5.0% | +2.5% | +5.2% | +6.6% | +6.2% | +2.0% | +4.9% | -4.0% | +6.6% | -2.5% | +3.8% | |
| – | -11.4% | -3.2% | +0.3% | -5.7% | -1.4% | +7.7% | +14.2% | -2.5% | +14.7% | +17.8% | -17.2% | |
| – | -23.7% | +3.3% | +6.9% | -20.5% | -16.0% | +27.0% | +32.2% | -17.5% | +20.0% | -39.5% | +35.5% | |
| – | -19.3% | -8.1% | -0.9% | -11.0% | -5.2% | +12.4% | +18.1% | -7.8% | +20.9% | -23.4% | +14.7% | |
| – | +15.5% | -0.6% | -1.4% | +3.8% | +5.2% | -0.5% | +3.3% | -0.7% | +17.7% | +5.1% | +3.7% | |
| – | +6.4% | +6.4% | +6.5% | +7.1% | +0.4% | +4.5% | +7.3% | +6.9% | +3.3% | +5.7% | +4.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.2% | -0.1% | -0.1% | +0.1% | -0.2% | +0.0% | +0.3% | -0.2% | +6.4% | +65.6% | -5.3% | |
| – | -93.9% | -13.6% | -15.1% | -11.8% | -9.1% | -14.8% | -8.7% | -19.0% | -23.4% | +1,463.1% | +14.1% | |
| – | -2.2% | -12.8% | +4.0% | +11.5% | +11.8% | -12.8% | +9.8% | +4.5% | +16.4% | -6.5% | +2.6% | |
| – | -1.1% | -17.1% | +8.2% | +12.7% | +4.1% | -11.9% | +10.0% | +6.5% | +11.3% | -4.7% | +0.6% | |
| – | – | +1,629.2% | -80.4% | +662.0% | -94.9% | – | – | – | – | – | – | |
| – | -3.8% | +3.0% | +0.0% | +12.5% | -11.6% | +42.8% | -3.4% | +9.1% | -12.4% | +30.5% | -16.7% | |
| – | +6.1% | +4.9% | +5.3% | +5.9% | +5.5% | +4.1% | +4.3% | -5.1% | +5.3% | -2.0% | +4.0% | |
| – | +12.7% | +6.9% | +10.1% | +9.8% | +11.0% | +4.9% | +6.5% | -15.5% | +9.2% | -8.8% | +6.9% | |
| – | +0.0% | +0.6% | +0.1% | +0.5% | +0.3% | +0.2% | -0.1% | -0.6% | -0.4% | -0.2% | -0.4% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.